2026

A New Chapter Begins

In 2026, Royston Instruments acquired a controlling stake in Biosan, marking the beginning of a significant new chapter. This partnership brings together complementary strengths and opens new opportunities for Biosan to deepen its global presence, accelerate product development, and continue serving the scientific community with the reliability and precision that have defined the company for over three decades.

2025

Sustainability and Brand Renewal

  • Biosan’s Quality Management System is certified to ISO 14001:2015, emphasizing environmental responsibility. 
  • Reflecting the core values of Biosan in our new identity, Biosan introduces the evolution of its logo and visual identity. The new logo reflects “laboratory blue” - stability and reliability, “medical green” - sustainability and trust and renewed font for “biosan” - honoring and respecting our history and roots. 

 

  • Biosan enters a new phase under new management 
  • Continuous product improvements reinforce the company’s commitment. During only 1 year we managed to introduce: 
    • 2 new products 
    • 3 product upgrades 
    • 8 accessories added 

 

Three new additions enter the portfolio: 

  • LMC-56 centrifuge with expanded capabilities and broader applications.  
  • ES-20/80C shaker-incubator – now with cooling and 400 rpm even when stacked. 
  • RCP-24 tissue homogenizer – completing the Tick-borne encephalitis detection solution. 
  • Biosan doubles its production capacity to meet rising global demand. 
  • Introduction of DEN-600, a compact, universal, battery-powered photometer entering the market of portable and mobile devices.  

COVID-19 hits the planet, and during this challenging time, Biosan, despite lockdowns and complete chaos with common logistics, launches the upgraded Biomagpure 12 Plus and introduces BioQuant-96 remaining a stable and trustworthy partner for the customers in more than 100 countries worldwide. 

  • Introduction of the ES-20/80, a next-generation device in the shaker-incubator product line. 
  • This is the first year Biosan expands the exhibition geography and participates in Medlab 2018 in Dubai. As will be known, MedLab becomes one of the “must have” exhibitions to attend every year. 

Launch of the S-Bt Compact CO₂ Incubator, showing Biosan’s dedication and ability to enter the highly specialized and demanding cell cultivation market.

Biosan introduces the complete solution - product line that covers whole NA extraction process and first iteration of Biomagpure 12 – a complete automated NA extraction system, coupling it with Biosan sample preparation devices 

Biosan receives The Red Jackets Award, recognized as one of the Top 25 Exporting Brands in Latvia.

Development of Biosan’s Microplate Photometer, enhancing precision in absorbance measurement applications.

Introduction of the RTS-1, featuring the patented Reverse Spin® technology, revolutionizing microbial cultivation approach. 

Biosan introduces a new logo. The logo symbolizes the living cell where energy “enters” through the letter “b” and “leaves” the system, providing the power for development.  

  • A new development strategy, "World of Biotechnomica", is launched to shape future innovation and define development strategy for coming years.     
  • Biosan enters into strategic partnership with UK-based Grant Instruments, forging a strong transnational partnership. 

Biosan's distribution network grows to 40 international dealers, solidifying its global footprint.

  • The unique and at that time revolutionary "Bioform" design concept is introduced, defining Biosan’s aesthetic and ergonomiapproach. 
  • The dealership network expands to 10 countries

Biosan participates in its first international exhibition, Biotechnica’95, marking its entrance into the global biotechnology market. United logo and systemized approach to brand identity along with clear concept for personal-use devices, helps establish relations with first big partners from countries like Japan, Korea, Germany, Israel 

The company joins the LTC Business Incubator, gaining support for early-stage expansion and research.

The company was founded by Vasily Bankovsky (Ph.D., Molecular Biology) and Svetlana Bankovska (MSc., Biochemistry) from the Institute of Microbiology in the Latvian Republic Academy of Science.